Cargando…

2610. Home Administration of Intranasal Live Attenuated Influenza Vaccine: A Review of Current Evidence and Potential for Meeting Vaccination Targets

BACKGROUND: During the 2010–2021 influenza seasons, vaccination coverage was below the 70% target for the United States at 33.4–58.6% among children and 50.2% among adults.[1, 2] The live attenuated influenza vaccine (LAIV) is currently approved for healthcare professional administration (HCPA); how...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jhaveri, Ravi, Zahn, Matt, Bandell, Allyn R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677229/ http://dx.doi.org/10.1093/ofid/ofad500.2224

Ejemplares similares

1401. Real-World Effectiveness of Inactivated and Live Attenuated Influenza Vaccines in Children During Three Recent Seasons: 2016–2019
por: Bandell, Allyn, et al.
Publicado: (2020)

1395. Influenza B-Associated Pediatric Mortality in the US Between 2010 and 2019
por: Bandell, Allyn, et al.
Publicado: (2020)

Acceptability of intranasal live attenuated influenza vaccine, influenza knowledge and vaccine intent in The Gambia
por: Armitage, Edwin P., et al.
Publicado: (2018)

Respiratory PCR detects influenza after intranasal live-attenuated influenza vaccination
por: Lumley, S, et al.
Publicado: (2013)

Influenza Virus Detection Following Administration of Live-Attenuated Intranasal Influenza Vaccine in Children With Cystic Fibrosis and Their Healthy Siblings
por: Boikos, Constantina, et al.
Publicado: (2016)

The administration of intranasal live attenuated influenza vaccine induces changes in the nasal microbiota and nasal epithelium gene expression profiles
por: Tarabichi, Y., et al.
Publicado: (2015)

Use of intranasal live attenuated influenza vaccine in individuals with asthma or a history of wheezing
por: Ambrose, Christopher S.
Publicado: (2012)

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
por: Chan, Kenneth Sik-Kwan, et al.
Publicado: (2022)

Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany
por: Damm, Oliver, et al.
Publicado: (2014)

Safety and Efficacy of Spray Intranasal Live Attenuated Influenza Vaccine: Systematic Review and Meta-Analysis
por: Perego, Giulia, et al.
Publicado: (2021)

Vaccination of children with a live-attenuated, intranasal influenza vaccine – analysis and evaluation through a Health Technology Assessment
por: Andersohn, Frank, et al.
Publicado: (2014)

Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets
por: Luczo, Jasmina M., et al.
Publicado: (2021)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
por: Sridhar, Saranya, et al.
Publicado: (2015)

Safety of Intranasal Quadrivalent Live Attenuated Influenza Vaccine (QLAIV) in Children and Adolescents: A Pilot Prospective Cohort Study in England
por: McNaughton, Rhian, et al.
Publicado: (2016)

Cost-effectiveness analysis of the direct and indirect impact of intranasal live attenuated influenza vaccination strategies in children: alternative country profiles
por: Gibson, Edward, et al.
Publicado: (2016)

Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza
por: Ambrose, Christopher S., et al.
Publicado: (2008)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

PB2610: EPIDEMIOLOGY AND TREATMENT OF ITP: A SINGLE CENTRE, REAL-WORLD EXPERIENCE
por: Patel, Priya, et al.
Publicado: (2023)

Beyond Influenza Vaccination: Expanding Infrastructure for Hospital-based Pediatric COVID-19 Vaccine Delivery
por: Hofstetter, Annika M., et al.
Publicado: (2022)

Immune responses after live attenuated influenza vaccination
por: Mohn, Kristin G.-I., et al.
Publicado: (2018)

Novel Approaches for The Development of Live Attenuated Influenza Vaccines
por: Blanco-Lobo, Pilar, et al.
Publicado: (2019)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Lee, Andrew Chak-Yiu, et al.
Publicado: (2021)

Broadly Neutralizing Antibodies for Influenza: Passive Immunotherapy and Intranasal Vaccination
por: Biswas, Mrityunjoy, et al.
Publicado: (2020)

1973. A Meta-Analysis of the Effectiveness of LAIV4 and IIV against Influenza A/H3N2 Strains in Children 2–18 Years of Age During the 2016–2017 Season
por: Mallory, Raburn, et al.
Publicado: (2018)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Concomitant administration of seasonal trivalent and pandemic monovalent H1N1 live attenuated influenza vaccines
por: Woo, Jennifer C., et al.
Publicado: (2009)

Live Attenuated Influenza Vaccines by Computer-Aided Rational Design
por: Mueller, Steffen, et al.
Publicado: (2010)

Principles underlying rational design of live attenuated influenza vaccines
por: Jang, Yo Han, et al.
Publicado: (2012)

Rationale for vaccination with trivalent or quadrivalent live attenuated influenza vaccines: Protective vaccine efficacy in the ferret model
por: Rudenko, Larisa, et al.
Publicado: (2018)

Clinical protection against caprine herpesvirus 1 genital infection by intranasal administration of a live attenuated glycoprotein E negative bovine herpesvirus 1 vaccine
por: Thiry, Julien, et al.
Publicado: (2007)

Quaternized chitosan nanoparticles loaded with the combined attenuated live vaccine against Newcastle disease and infectious bronchitis elicit immune response in chicken after intranasal administration
por: Zhao, Kai, et al.
Publicado: (2017)

584. Phase 1 Placebo-Controlled Trial of COVI-VAC™, an Intranasal, Live Attenuated COVID-19 Vaccine
por: Tasker, Sybil, et al.
Publicado: (2021)

Multiradionuclide evidence for an extreme solar proton event around 2,610 B.P. (∼660 BC)
por: O’Hare, Paschal, et al.
Publicado: (2019)

2610. A Deadly Intrusion: Competitive Strain Displacement among Dengue Virus Strains in Sri lanka
por: Gallegos, Dylan C, et al.
Publicado: (2019)

Intranasal Delivery of Influenza Subunit Vaccine Formulated with GEM Particles as an Adjuvant
por: Saluja, Vinay, et al.
Publicado: (2010)

Severity of heterosubtypic influenza virus infection in ferrets is reduced by live attenuated influenza vaccine
por: Marriott, Anthony C., et al.
Publicado: (2021)

Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity
por: Roy, Sreeja, et al.
Publicado: (2020)

2015–2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States
por: Poehling, Katherine A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_obsoedhvvnoist9nplq4s6jsva